Insider transaction details
Director Stephen F. Page of AeroVironment Inc (NASDAQ: AVAV) sold 250 shares of common stock on March 16, 2026. The shares traded at $212.52 each, producing gross proceeds of $53,130. Following the sale, Page continues to hold shares both indirectly and directly: the Stephen F. Page Living Trust holds 49,751 shares indirectly, and Page personally retains 1,705 shares.
The disposition was completed under a pre-arranged Rule 10b5-1 trading plan that the Stephen F. Page Living Trust adopted on September 30, 2025. The use of a 10b5-1 plan indicates the trade was scheduled in advance of the execution date under the terms of that plan.
Market context and valuation
At the time of reporting, AVAV shares were trading at $222.51, which is notably higher than InvestingPro's stated Fair Value of $163.71. That valuation gap places the stock on InvestingPro's Most Overvalued list. The shares have returned 77% over the last 12 months but have fallen 18% in the past six months.
Operational and strategic developments
Separately from the insider sale, AeroVironment announced the acquisition of Empirical Systems Aerospace, Inc. (ESAero) for approximately $200 million. The purchase consideration is expected to consist of $160 million in stock with the remaining amount paid in cash. The company indicated that the transaction is expected to have a positive impact on adjusted EBITDA within the first year following closing.
Recent published results show AeroVironment's fiscal third-quarter revenue at $408 million and adjusted EBITDA of $44.5 million. The company has faced execution challenges related to the SCAR program, which management and analysts have cited when reassessing outlooks.
Analyst reactions and target revisions
Following the operational updates and the acquisition announcement, several brokerage firms revised their price targets on AVAV:
- Stifel lowered its target to $315 while maintaining a Buy rating, citing timing issues and adjustments within the Space business.
- RBC Capital reduced its target to $250, pointing to lower visibility for revenue and EBITDA.
- KeyBanc adjusted its target to $295 and kept an Overweight rating.
- Needham decreased its target to $400 while maintaining a Buy rating, attributing the change to delays caused by a stop-work order and shifts in program timing.
Further research and valuation resources
For investors seeking additional valuation context and detailed financial analysis, the company and its metrics are covered in InvestingPro's Pro Research Report, available through that service. The InvestingPro fair-value estimate and the Most Overvalued designation noted above are drawn from that platform's published work.
Concluding note
The insider sale by Director Stephen F. Page was executed through an established 10b5-1 plan. It occurred against a backdrop of a completed acquisition, recent quarterly results that included reported program difficulties, and several analysts adjusting targets and outlooks. Together, these items frame the current market and valuation debate surrounding AVAV.